LEXX (STOCKS)
Lexaria Bioscience Corp. Common Stock
$0.650000
+0.035500 (+5.78%)
Prev close: $0.614500
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Richard C. Christopher
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $15.29M
- Employees
- 7
- P/E (TTM)
- -1.27
- P/B (TTM)
- 2.32
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
2
Strong Buy
4
Buy
1
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Mar 2026 (Q2)
|
$-0.06 | $-0.10 | +0.0369 | +38.08% |
|
Dec 2025 (Q1)
|
$-0.07 | $-0.13 | +0.0626 | +47.21% |
|
Sep 2025 (Q4)
|
$-0.13 | $-0.16 | +0.0298 | +18.65% |
|
Jun 2025 (Q3)
|
$-0.21 | $-0.16 | -0.0502 | -31.41% |
Financial Statements
| Revenues | $522.00K |
| Cost Of Revenue | $0.00 |
| Gross Profit | $522.00K |
| Nonoperating Income/Loss | -$36.86K |
| Operating Expenses | $11.29M |
| Depreciation and Amortization | $71.50K |
| Research and Development | $6.96M |
| Other Operating Expenses | $4.29M |
| Operating Income/Loss | -$10.76M |
| Income/Loss From Continuing Operations After Tax | -$10.80M |
| Income/Loss From Continuing Operations Before Tax | -$10.80M |
| Net Income/Loss | -$10.80M |
| Net Income/Loss Attributable To Noncontrolling Interest | -$9.16K |
| Net Income/Loss Attributable To Parent | -$10.79M |
| Net Income/Loss Available To Common Stockholders, Basic | -$10.79M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Diluted Earnings Per Share | -$0.56 |
| Diluted Average Shares | 57,712,117 |
| Assets | $6.05M |
| Current Assets | $5.36M |
| Noncurrent Assets | $687.68K |
| Long Term Investments | $64.01K |
| Fixed Assets | $216.12K |
| Other Non-current Assets | $407.55K |
| Liabilities | $1.53M |
| Current Liabilities | $1.46M |
| Noncurrent Liabilities | $70.82K |
| Equity | $4.52M |
| Equity Attributable To Noncontrolling Interest | -$389.44K |
| Equity Attributable To Parent | $4.91M |
| Liabilities And Equity | $6.05M |
| Net Cash Flow From Operating Activities | -$8.71M |
| Net Cash Flow From Operating Activities, Continuing | -$8.71M |
| Net Cash Flow From Investing Activities | -$210.31K |
| Net Cash Flow From Investing Activities, Continuing | -$210.31K |
| Net Cash Flow From Financing Activities | $5.17M |
| Net Cash Flow From Financing Activities, Continuing | $5.17M |
| Exchange Gains/Losses | -$53.09K |
| Net Cash Flow | -$3.80M |
| Net Cash Flow, Continuing | -$3.74M |
| Comprehensive Income/Loss | -$10.75M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$10.85M |
| Other Comprehensive Income/Loss | $47.57K |